Related references
Note: Only part of the references are listed.miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7
Chuanyi Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment
Bing Feng et al.
CLINICAL SCIENCE (2015)
MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer
Eduardo Tormo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
L. Roca-Alonso et al.
CELL DEATH & DISEASE (2015)
miR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation
Gengsheng He et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
miRNA and Cancer; Computational and Experimental Approaches
Yusuf Tutar
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN
Guangjun Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
miR-92a family and their target genes in tumorigenesis and metastasis
Molin Li et al.
EXPERIMENTAL CELL RESEARCH (2014)
miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression
Chifumi Ohyagi-Hara et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells
H-Y Lin et al.
BRITISH JOURNAL OF CANCER (2013)
miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells
Shanliang Zhong et al.
GENE (2013)
miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A
Xiaolan Zhu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Correction: In Vitro Evolution of Allergy Vaccine Candidates, with Maintained Structure, but Reduced B Cell and T Cell Activation Capacity
Ola B. Nilsson et al.
PLoS One (2012)
Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders
S. Yoshizawa et al.
BLOOD CANCER JOURNAL (2012)
miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer
Akihiko Tsuchida et al.
CANCER SCIENCE (2011)
microRNA-92a Promotes Lymph Node Metastasis of Human Esophageal Squamous Cell Carcinoma via E-Cadherin
Zhao-li Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MicroRNA in lung cancer diagnostics and treatment
Marcin Skrzypski et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma
Kazuma Ohyashiki et al.
PLOS ONE (2011)
Molecular oncology of lung cancer
Shinichi Toyooka et al.
GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2011)
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN
Zhang Chun-zhi et al.
BMC CANCER (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Richard Hummel et al.
EUROPEAN JOURNAL OF CANCER (2010)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Origins and Mechanisms of miRNAs and siRNAs
Richard W. Carthew et al.
CELL (2009)
Recent Advances in Protection Against Doxorubicin-induced Toxicity
Rade Injac et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2008)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
A microRNA expression signature of human solid tumors defines cancer gene targets
S Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
The role of PKCα and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer
SS Singhal et al.
FEBS LETTERS (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Towards a complete description of the microRNA complement of animal genomes
J Brennecke et al.
GENOME BIOLOGY (2003)
Share Paper
